The Food and Drug Administration (FDA) has directed BioNTech and Moderna to expand the warning labels on the COVID-19 vaccine to include warnings for heart inflammation.
The U.S. Food and Drug Administration (FDA) has announced plans to remove concentrated ingestible fluoride prescription drug products for children from the market, citing potential health risks.
The U.S. Food and Drug Administration (FDA) announced a sweeping overhaul of how it reviews chemicals already present in the American food supply. The new system will fast-track investigations into several additives long used in consumer goods, including some that have been banned in Europe.
A recent analysis indicates that over 5% of women who took mifepristone for abortion required a second procedure within 45 days, highlighting potential issues with the pill's effectiveness.
Neuralink announced that it has received the U.S. Food and Drug Administration's (FDA) "breakthrough" tag to restore communication for those with severe speech impairment.
The Illinois House of Representatives, led by Democrats, has passed House Bill 3637, aiming to ensure continued access to abortion medication, specifically mifepristone, regardless of potential federal restrictions.
The U.S. Food and Drug Administration (FDA) has announced a recall of multiple over-the-counter acne treatments due to the presence of benzene, a chemical linked to cancer. Retailers have been instructed to remove the affected products from shelves and online marketplaces.
The Food and Drug Administration (FDA) has announced a recall of nearly 2,800 containers of First Aid Beauty’s Ultra Repair Cream in Coconut Vanilla due to a “Current Good Manufacturing Practice deviation.”